NASDAQ:CDLX - Cardlytics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$20.02 +0.15 (+0.75 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$20.02
Today's Range$19.65 - $20.3261
52-Week Range$11.10 - $22.57
Volume103,341 shs
Average Volume198,618 shs
Market Capitalization$402.65 million
P/E Ratio-2.50
Dividend YieldN/A
BetaN/A

About Cardlytics (NASDAQ:CDLX)

Cardlytics logoCardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Debt-to-Equity Ratio0.81
Current Ratio1.68
Quick Ratio1.68

Price-To-Earnings

Trailing P/E Ratio-2.50
Forward P/E Ratio-10.16
P/E GrowthN/A

Sales & Book Value

Annual Sales$130.37 million
Price / Sales3.11
Cash FlowN/A
Price / CashN/A
Book Value$2.00 per share
Price / Book10.01

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees342
Outstanding Shares20,260,000

Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How were Cardlytics' earnings last quarter?

Cardlytics (NASDAQ:CDLX) released its quarterly earnings results on Monday, March, 19th. The company reported ($1.10) earnings per share for the quarter, beating the consensus estimate of ($1.35) by $0.25. The firm had revenue of $39.27 million for the quarter, compared to analysts' expectations of $38.48 million. View Cardlytics' Earnings History.

What price target have analysts set for CDLX?

6 equities research analysts have issued 12-month price targets for Cardlytics' shares. Their forecasts range from $19.00 to $25.00. On average, they anticipate Cardlytics' share price to reach $22.40 in the next twelve months. View Analyst Ratings for Cardlytics.

Are investors shorting Cardlytics?

Cardlytics saw a increase in short interest in the month of April. As of April 30th, there was short interest totalling 861,027 shares, an increase of 40.0% from the April 13th total of 614,820 shares. Based on an average trading volume of 94,969 shares, the short-interest ratio is presently 9.1 days. Approximately 10.2% of the shares of the stock are sold short.

Who are some of Cardlytics' key competitors?

Who are Cardlytics' key executives?

Cardlytics' management team includes the folowing people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
  • Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Has Cardlytics been receiving favorable news coverage?

Media coverage about CDLX stock has trended somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardlytics earned a coverage optimism score of 0.16 on Accern's scale. They also gave news headlines about the company an impact score of 45.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Polaris Venture Management Co. V L.L.C. (13.18%), Federated Investors Inc. PA (2.00%), BlackRock Inc. (1.17%), Millennium Management LLC (0.87%), Citadel Advisors LLC (0.53%) and Kornitzer Capital Management Inc. KS (0.31%). Company insiders that own Cardlytics stock include David Thomas Evans and Scott D Grimes. View Institutional Ownership Trends for Cardlytics.

Which major investors are buying Cardlytics stock?

CDLX stock was bought by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Federated Investors Inc. PA, BlackRock Inc., Millennium Management LLC, Citadel Advisors LLC, Kornitzer Capital Management Inc. KS, Northern Trust Corp and Penn Capital Management Co. Inc.. Company insiders that have bought Cardlytics stock in the last two years include David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $20.02.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $402.65 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]


MarketBeat Community Rating for Cardlytics (CDLX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  19 (Vote Underperform)
Total Votes:  39
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardlytics (NASDAQ:CDLX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Cardlytics in the last 12 months. Their average twelve-month price target is $22.40, suggesting that the stock has a possible upside of 11.89%. The high price target for CDLX is $25.00 and the low price target for CDLX is $19.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 2.832.83N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.40$22.40N/AN/A
Price Target Upside: 11.89% upside64.71% upsideN/AN/A

Cardlytics (NASDAQ:CDLX) Consensus Price Target History

Price Target History for Cardlytics (NASDAQ:CDLX)

Cardlytics (NASDAQ:CDLX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/23/2018GabelliReiterated RatingBuyLowView Rating Details
3/6/2018SunTrust BanksInitiated CoverageBuy ➝ Buy$25.00LowView Rating Details
3/6/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$23.00LowView Rating Details
3/6/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$25.00 ➝ $19.00LowView Rating Details
3/6/2018Wells Fargo & CoInitiated CoverageOutperform ➝ Outperform$22.00LowView Rating Details
3/6/2018KeyCorpInitiated CoverageOverweight ➝ Overweight$23.00LowView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Cardlytics (NASDAQ:CDLX) Earnings History and Estimates Chart

Earnings by Quarter for Cardlytics (NASDAQ:CDLX)

Cardlytics (NASDAQ:CDLX) Earnings Estimates

2018 EPS Consensus Estimate: ($1.86)
2019 EPS Consensus Estimate: ($0.76)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.66)($0.57)($0.62)
Q2 20182($0.44)($0.41)($0.43)
Q3 20182($0.57)($0.53)($0.55)
Q4 20182($0.33)($0.21)($0.27)
Q1 20191($0.41)($0.41)($0.41)
Q2 20191($0.20)($0.20)($0.20)
Q3 20191($0.17)($0.17)($0.17)
Q4 20191$0.02$0.02$0.02

Cardlytics (NASDAQ CDLX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/19/2018Q4 2017($1.35)($1.10)$38.48 million$39.27 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cardlytics (NASDAQ:CDLX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cardlytics (NASDAQ CDLX) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 48.32%
Insider Trading History for Cardlytics (NASDAQ:CDLX)
Insider Trading History for Cardlytics (NASDAQ:CDLX)

Cardlytics (NASDAQ CDLX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2018David Thomas EvansCFOBuy1,500$13.00$19,500.00View SEC Filing  
2/13/2018Scott D GrimesCEOBuy2,600$13.00$33,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cardlytics (NASDAQ CDLX) News Headlines

Source:
DateHeadline
Cardlytics to Present at the Bank of America Merrill Lynch 2018 Global Technology ConferenceCardlytics to Present at the Bank of America Merrill Lynch 2018 Global Technology Conference
finance.yahoo.com - May 24 at 3:20 PM
Cardlytics (CDLX) Given Consensus Recommendation of "Buy" by AnalystsCardlytics (CDLX) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 20 at 5:25 AM
 Brokerages Expect Cardlytics (CDLX) Will Announce Quarterly Sales of $36.11 Million Brokerages Expect Cardlytics (CDLX) Will Announce Quarterly Sales of $36.11 Million
www.americanbankingnews.com - May 16 at 4:24 AM
Corporate Counsel Awards 2018: Somers ensured Cardlytics’ IPO would be successfulCorporate Counsel Awards 2018: Somers ensured Cardlytics’ IPO would be successful
finance.yahoo.com - May 14 at 3:19 PM
Cardlytics: A Difficult Story To Believe InCardlytics: A Difficult Story To Believe In
seekingalpha.com - May 14 at 7:15 AM
Cardlytics (CDLX) Expected to Post Earnings of -$0.39 Per ShareCardlytics (CDLX) Expected to Post Earnings of -$0.39 Per Share
www.americanbankingnews.com - May 14 at 5:33 AM
Short Interest in Cardlytics (CDLX) Grows By 40.0%Short Interest in Cardlytics (CDLX) Grows By 40.0%
www.americanbankingnews.com - May 13 at 2:02 AM
Cardlytics beats by $0.27, beats on revenueCardlytics beats by $0.27, beats on revenue
seekingalpha.com - May 11 at 7:18 AM
Cardlytics (CDLX) CEO Scott Grimes on Q1 2018 Results - Earnings Call TranscriptCardlytics' (CDLX) CEO Scott Grimes on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 7:18 AM
Cardlytics Announces First Quarter 2018 Financial ResultsCardlytics Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 11 at 7:18 AM
Critical Comparison: Cardlytics (CDLX) vs. Its CompetitorsCritical Comparison: Cardlytics (CDLX) vs. Its Competitors
www.americanbankingnews.com - May 1 at 1:08 AM
Financial Comparison: Cardlytics (CDLX) vs. Its PeersFinancial Comparison: Cardlytics (CDLX) vs. Its Peers
www.americanbankingnews.com - April 28 at 9:26 AM
Cardlytics (CDLX) Expected to Announce Quarterly Sales of $29.74 MillionCardlytics (CDLX) Expected to Announce Quarterly Sales of $29.74 Million
www.americanbankingnews.com - April 28 at 2:32 AM
-$0.51 Earnings Per Share Expected for Cardlytics (CDLX) This Quarter-$0.51 Earnings Per Share Expected for Cardlytics (CDLX) This Quarter
www.americanbankingnews.com - April 26 at 5:20 PM
Cardlytics Announces Timing of Its First Quarter 2018 Financial Results Conference Call and WebcastCardlytics Announces Timing of Its First Quarter 2018 Financial Results Conference Call and Webcast
feeds.benzinga.com - April 25 at 4:27 PM
Cardlytics (CDLX) Forecasted to Earn FY2018 Earnings of ($0.85) Per ShareCardlytics (CDLX) Forecasted to Earn FY2018 Earnings of ($0.85) Per Share
www.americanbankingnews.com - April 25 at 9:44 AM
Gabelli Reaffirms Buy Rating for Cardlytics (CDLX)Gabelli Reaffirms Buy Rating for Cardlytics (CDLX)
www.americanbankingnews.com - April 25 at 8:24 AM
Cardlytics (CDLX) Receives Consensus Rating of "Buy" from BrokeragesCardlytics (CDLX) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 25 at 7:42 AM
Cardlytics (CDLX) versus Its Competitors Head-To-Head ContrastCardlytics (CDLX) versus Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - April 23 at 9:14 AM
Contrasting Cardlytics (CDLX) and Its RivalsContrasting Cardlytics (CDLX) and Its Rivals
www.americanbankingnews.com - April 20 at 7:18 PM
Cardlytics Chief Legal Officer Named Atlanta Business Chronicle’s Corporate Counsel of the YearCardlytics Chief Legal Officer Named Atlanta Business Chronicle’s Corporate Counsel of the Year
finance.yahoo.com - April 20 at 3:19 PM
Cardlytics (CDLX) & Its Rivals Financial ContrastCardlytics (CDLX) & Its Rivals Financial Contrast
www.americanbankingnews.com - April 19 at 9:04 PM
 Analysts Anticipate Cardlytics Inc (CDLX) Will Post Quarterly Sales of $29.74 Million Analysts Anticipate Cardlytics Inc (CDLX) Will Post Quarterly Sales of $29.74 Million
www.americanbankingnews.com - April 11 at 2:19 AM
Zacks: Analysts Anticipate Cardlytics Inc (CDLX) Will Post Earnings of -$0.51 Per ShareZacks: Analysts Anticipate Cardlytics Inc (CDLX) Will Post Earnings of -$0.51 Per Share
www.americanbankingnews.com - April 9 at 7:20 PM
Zacks: Cardlytics Inc (CDLX) Given Average Recommendation of "Buy" by BrokeragesZacks: Cardlytics Inc (CDLX) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 9 at 5:37 AM
Head-To-Head Contrast: Cardlytics (CDLX) vs. Weibo (WB)Head-To-Head Contrast: Cardlytics (CDLX) vs. Weibo (WB)
www.americanbankingnews.com - April 6 at 7:21 PM
Comparing Cardlytics (CDLX) and Its CompetitorsComparing Cardlytics (CDLX) and Its Competitors
www.americanbankingnews.com - April 2 at 3:06 AM
Zacks: Cardlytics Inc (CDLX) Receives Average Rating of "Buy" from AnalystsZacks: Cardlytics Inc (CDLX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - March 25 at 7:26 PM
Cardlytics (CDLX) Now Covered by KeyCorpCardlytics (CDLX) Now Covered by KeyCorp
www.americanbankingnews.com - March 24 at 11:24 AM
Cardlytics (CDLX) Earns Outperform Rating from Analysts at Wells FargoCardlytics (CDLX) Earns Outperform Rating from Analysts at Wells Fargo
www.americanbankingnews.com - March 24 at 11:24 AM
Zacks: Analysts Anticipate Cardlytics Inc (CDLX) Will Announce Earnings of -$0.51 Per ShareZacks: Analysts Anticipate Cardlytics Inc (CDLX) Will Announce Earnings of -$0.51 Per Share
www.americanbankingnews.com - March 23 at 7:26 PM
Zacks: Cardlytics Inc (CDLX) Receives Consensus Recommendation of "Buy" from BrokeragesZacks: Cardlytics Inc (CDLX) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 22 at 5:44 PM
Analysts Offer Predictions for Cardlytics Incs Q1 2018 Earnings (CDLX)Analysts Offer Predictions for Cardlytics Inc's Q1 2018 Earnings (CDLX)
www.americanbankingnews.com - March 22 at 9:06 AM
KeyCorp Brokers Cut Earnings Estimates for Cardlytics Inc (CDLX)KeyCorp Brokers Cut Earnings Estimates for Cardlytics Inc (CDLX)
www.americanbankingnews.com - March 22 at 9:06 AM
Analysts Set Expectations for Cardlytics Incs FY2021 Earnings (CDLX)Analysts Set Expectations for Cardlytics Inc's FY2021 Earnings (CDLX)
www.americanbankingnews.com - March 21 at 4:18 PM
Cardlytics Inc Forecasted to Earn Q4 2019 Earnings of $0.02 Per Share (CDLX)Cardlytics Inc Forecasted to Earn Q4 2019 Earnings of $0.02 Per Share (CDLX)
www.americanbankingnews.com - March 21 at 4:00 PM
Cardlytics beats by $0.15, beats on revenueCardlytics beats by $0.15, beats on revenue
seekingalpha.com - March 21 at 5:34 AM
Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and WebcastCardlytics Announces Timing of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast
www.streetinsider.com - March 21 at 5:34 AM
Cardlytics Announces Fourth Quarter and Full Year 2017 Financial ResultsCardlytics Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 20 at 5:40 AM
Zacks: Analysts Set $22.17 Target Price for Cardlytics Inc (CDLX)Zacks: Analysts Set $22.17 Target Price for Cardlytics Inc (CDLX)
www.americanbankingnews.com - March 19 at 3:24 AM
Head-To-Head Analysis: Cardlytics (CDLX) versus Mattersight (MATR)Head-To-Head Analysis: Cardlytics (CDLX) versus Mattersight (MATR)
www.americanbankingnews.com - March 16 at 9:06 PM
Analysts Anticipate Cardlytics Inc (CDLX) to Announce ($0.33) EPSAnalysts Anticipate Cardlytics Inc (CDLX) to Announce ($0.33) EPS
www.americanbankingnews.com - March 15 at 4:00 PM
Financial Survey: Cardlytics (CDLX) versus Harte Hanks (HHS)Financial Survey: Cardlytics (CDLX) versus Harte Hanks (HHS)
www.americanbankingnews.com - March 14 at 1:26 AM
Cardlytics Incs Quiet Period To End  on March 21st (NASDAQ:CDLX)Cardlytics Inc's Quiet Period To End on March 21st (NASDAQ:CDLX)
www.americanbankingnews.com - March 14 at 1:16 AM
Cardlytics (CDLX) and Harte Hanks (HHS) Head to Head SurveyCardlytics (CDLX) and Harte Hanks (HHS) Head to Head Survey
www.americanbankingnews.com - March 12 at 7:08 PM
Cardlytics (CDLX) Scheduled to Post Earnings on MondayCardlytics (CDLX) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - March 12 at 2:20 AM
 Analysts Set $22.17 Target Price for Cardlytics Inc (CDLX) Analysts Set $22.17 Target Price for Cardlytics Inc (CDLX)
www.americanbankingnews.com - March 11 at 5:54 PM
Mattersight (MATR) versus Cardlytics (CDLX) Critical SurveyMattersight (MATR) versus Cardlytics (CDLX) Critical Survey
www.americanbankingnews.com - March 9 at 1:12 AM
 Brokerages Set $22.20 Target Price for Cardlytics Inc (CDLX) Brokerages Set $22.20 Target Price for Cardlytics Inc (CDLX)
www.americanbankingnews.com - March 8 at 9:29 PM
Research Analysts Issue Forecasts for Cardlytics Incs FY2017 Earnings (CDLX)Research Analysts Issue Forecasts for Cardlytics Inc's FY2017 Earnings (CDLX)
www.americanbankingnews.com - March 8 at 6:31 AM

SEC Filings

Cardlytics (NASDAQ:CDLX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Cardlytics (NASDAQ CDLX) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.